chloroplast
genet
engin
offer
sever
advantag
includ
high
level
transgen
express
transgen
contain
via
matern
inherit
multigen
express
singl
transform
event
oral
deliveri
facilit
hyperexpress
vaccin
antigen
cholera
tetanu
anthrax
plagu
canin
parvoviru
total
solubl
protein
tsp
transgen
chloroplast
leav
nongreen
plastid
carrot
tomato
well
avail
antibiot
free
select
marker
abil
excis
select
marker
gene
hyperexpress
sever
therapeut
protein
includ
human
serum
albumin
tsp
somatotropin
tsp
interferonalpha
tsp
interferongamma
tsp
antimicrobi
peptid
tsp
facilit
effici
econom
purif
also
presenc
chaperon
enzym
chloroplast
facilit
assembl
complex
multisubunit
protein
correct
fold
human
blood
protein
proper
disulfid
bond
function
chloroplastderiv
vaccin
antigen
therapeut
protein
demonstr
sever
assay
includ
macrophag
lysi
assay
bind
assay
protect
hela
cell
human
lung
carcinoma
cell
encephalomyocard
viru
system
immun
respons
protect
pathogen
challeng
growth
inhibit
cell
cultur
purif
human
proinsulin
achiev
use
novel
purif
strategi
invers
temperatur
transit
properti
requir
expens
column
chromatographi
techniqu
thu
transgen
chloroplast
ideal
bioreactor
product
function
human
anim
therapeut
protein
environment
friendli
manner
vaccin
therapeut
protein
great
success
modern
medicin
use
sever
decad
prevent
diseas
erad
use
vaccin
therapeut
protein
great
potenti
limit
cost
product
distribut
deliveri
modifi
mammalian
cell
use
produc
therapeut
protein
advantag
result
product
similar
natur
counterpart
cell
cultur
limit
scale
product
quit
expens
bacteria
use
largescal
product
protein
product
differ
natur
product
consider
exampl
protein
usual
glycosyl
human
glycosyl
bacteria
moreov
mani
protein
express
escherichia
coli
larg
scale
sometim
may
differ
conform
eventu
precipit
due
lack
proper
fold
disulfid
bridg
daniel
et
al
age
human
use
plant
sourc
food
cloth
medicin
build
materi
plant
immens
help
past
continu
plant
one
new
host
product
biopharmaceut
polym
vaccin
enzym
plasma
protein
antibodi
mani
advantag
product
recombin
protein
plant
primarili
plant
system
econom
produc
larg
scale
rather
use
industri
method
ferment
bacteria
yeast
cultur
anim
human
cell
line
expens
also
need
maintain
cold
chain
plant
part
express
vaccin
plant
extract
store
transport
room
temperatur
plant
abil
carri
posttransl
modif
similar
natur
occur
system
also
minim
risk
contamin
potenti
human
pathogen
plant
host
human
infecti
agent
gid
et
al
therapeut
protein
deliv
oral
purif
step
plant
elimin
advantag
foodbas
vaccin
includ
low
cost
raw
materi
conveni
storag
cost
syring
needl
deliveri
vaccin
elimin
therebi
elimin
bloodborn
pathogen
mani
differ
protein
applic
human
anim
vaccin
biopharmaceut
biopolym
express
transgen
plant
except
often
low
express
level
foreign
protein
less
total
solubl
protein
observ
nuclear
transgen
plant
daniel
et
al
includ
b
subunit
enterotoxigen
e
coli
tsp
haq
et
al
hepat
b
viru
envelop
surfac
protein
tsp
mason
et
al
thanavala
et
al
human
cytomegaloviru
glycoprotein
b
tsp
tackaberri
et
al
transmiss
gastroenter
coronaviru
glycoprotein
tsp
gomez
et
al
also
gene
silenc
occur
nuclear
transform
result
lower
express
recombin
protein
commerci
exploit
therapeut
protein
vaccin
antigen
high
reliabl
level
express
requir
could
achiev
altern
approach
highest
level
protein
express
bacillu
thuringiensi
bt
plant
achiev
tsp
transgen
tobacco
chloroplast
de
cosa
et
al
besid
high
express
level
sever
advantag
chloroplast
genet
engin
nuclear
transform
chloroplast
genom
defi
law
mendelian
inherit
matern
inherit
crop
zhang
et
al
thu
minim
outcross
transgen
pollen
relat
weed
crop
even
pollen
plant
exhibit
matern
inherit
contain
metabol
activ
plastid
plastid
dna
lost
pollen
matur
transmit
next
gener
daniel
therefor
chloroplast
express
system
environment
friendli
approach
also
chloroplast
abil
express
multipl
gene
singl
transform
event
express
polycistron
transgen
chloroplast
uniqu
featur
facilit
express
entir
pathway
singl
transform
event
de
cosa
et
al
daniel
dhingra
first
time
complet
bacteri
operon
success
express
transgen
chloroplast
result
format
stabl
crystal
de
cosa
et
al
facilit
express
polyval
vaccin
multisubunit
protein
transgen
chloroplast
addit
posit
effect
seen
nuclear
transgen
elimin
transgen
target
spacer
region
precis
locat
chloroplast
genom
homolog
recombin
chloroplast
dna
flank
sequenc
problem
gene
silenc
observ
transgen
chloroplast
spite
higher
express
level
nuclear
transgen
plant
observ
gene
silenc
spite
high
translat
level
tsp
de
cosa
et
al
transcript
transgen
chloroplast
despit
accumul
transcript
higher
nuclear
transgen
lee
et
al
dhingra
et
al
chloroplast
also
abil
process
eukaryot
protein
includ
correct
fold
subunit
format
disulfid
bridg
daniel
et
al
function
assay
show
chloroplastsynthes
cholera
toxinb
subunit
bind
intestin
membran
receptor
therebi
confirm
correct
fold
disulfid
bond
format
staub
et
al
daniel
et
al
molina
et
al
chaperon
present
chloroplast
facilit
correct
fold
assembl
monoclon
antibodi
transgen
chloroplast
daniel
et
al
also
result
fulli
function
human
therapeut
protein
seen
interferon
alpha
gamma
falcon
leelavathi
reddi
chloroplast
good
place
store
biosynthet
product
could
otherwis
harm
accumul
cytosol
bogorad
demonstr
cholera
toxin
b
subunit
accumul
larg
quantiti
transgen
chloroplast
toxic
effect
daniel
et
al
wherea
accumul
cytosol
small
quantiti
ctb
toxic
mason
et
al
similarli
trehalos
use
preserv
pharmaceut
industri
toxic
accumul
cytosol
nontox
compartment
within
chloroplast
lee
et
al
sever
therapeut
protein
vaccin
antigen
express
via
chloroplast
genom
list
tabl
main
reason
high
cost
pharmaceut
protein
product
purif
recombin
protein
therefor
novel
protein
purif
strategi
use
requir
use
expens
column
chromatographi
instanc
synthet
proteinbas
polym
gene
gvgvp
express
e
coli
high
express
level
achiev
polym
inclus
bodi
form
occupi
nearli
cell
volum
daniel
et
al
guda
et
al
gvgvp
exhibit
invers
temperatur
transit
properti
make
solubl
water
room
temperatur
aggreg
order
viscoelast
state
call
coacerv
daniel
et
al
guda
et
al
invers
temperatur
transit
properti
make
purif
easier
less
expens
aqueou
solut
simpli
rais
temperatur
addit
properti
make
gvgvp
ideal
fusion
protein
purif
demonstr
proinsulin
gene
fuse
smaller
version
biopolym
gvgvp
invers
temperatur
transit
properti
express
e
coli
daniel
et
al
biopolym
exist
extend
molecul
incub
fold
dynam
structur
call
aggreg
hydrophob
associ
form
twist
filament
urri
et
al
therefor
principl
success
use
purifi
fusion
protein
simpli
rais
temperatur
analyz
sdspolyacrylamid
gel
presenc
polym
proinsulinpolym
fusion
protein
confirm
neg
stain
sdspage
gel
fig
copper
stain
gel
illumin
obliqu
show
dark
band
light
semiopaqu
background
gel
stain
coomassi
sulphon
acid
group
dye
coomassi
form
ion
pair
lysin
arginin
protein
present
polym
present
proinsulin
sinc
coomassi
stain
polypeptid
confirm
presenc
fusion
protein
fig
purif
fusion
protein
cleav
suitabl
enzym
polym
discard
pellet
fraction
anoth
round
polymer
follow
centrifug
novel
purif
strategi
significantli
decreas
purif
cost
elimin
column
chromatographi
oral
deliveri
vaccin
attract
altern
eas
administr
low
cost
also
oral
deliveri
recombin
protein
could
reduc
product
cost
almost
point
chloroplast
genet
engin
suitabl
hyperexpress
vaccin
antigen
therapeut
protein
howev
oral
deliveri
vaccin
antigen
could
significantli
reduc
cost
product
purif
storag
transport
therebi
elimin
need
maintain
cold
chain
achiev
oral
deliveri
vaccin
one
import
requir
product
therapeut
protein
antibiot
free
select
transform
techniqu
use
antibiot
resist
gene
along
gene
interest
transgen
line
contain
desir
trait
select
trait
establish
antibiot
resist
gene
one
purpos
produc
product
one
major
concern
horizont
transfer
antibiot
resist
gene
relat
unrel
organ
howev
chloroplast
genet
modifi
without
use
antibiot
resist
gene
sever
way
exampl
spinach
betain
aldehyd
dehydrogenas
badh
gene
develop
select
marker
transform
chloroplast
genom
daniel
et
al
e
toxic
betain
aldehyd
ba
convert
nontox
glycin
betain
chloroplast
badh
enzym
glycin
betain
also
serv
osmoprotect
confer
salt
toler
kumar
et
al
badh
enzym
present
plant
speci
adapt
salti
dri
environ
addit
select
marker
gene
remov
use
short
dna
repeat
gene
interest
could
retain
outsid
direct
repeat
therebi
produc
markerfre
plant
iatham
day
anoth
method
elimin
select
marker
employ
transient
cointegr
vector
singl
homolog
flank
klau
et
al
cointegr
lost
rapidli
recombin
select
pressur
remov
oral
deliveri
vaccin
anoth
import
requir
express
vaccin
antigen
plastid
nongreen
tissu
first
time
stabl
highli
effici
plastid
transform
carrot
use
nongreen
tissu
explant
regener
via
somat
embryogenesi
report
kumar
et
al
use
plant
trait
salt
toler
express
first
time
nonsolanac
crop
via
chloroplast
genom
carrotspecif
plastid
transform
vector
pdddcaadabadh
construct
carrot
callu
bombard
bombard
callu
plate
select
medium
contain
mgl
spectinomycin
obtain
spectinomycinresist
transgen
line
badh
enzym
activ
assay
crude
extract
protein
transform
untransform
carrot
cell
cultur
badh
enzym
presenc
betain
aldehyd
convert
nad
nadh
reaction
rate
measur
increas
absorb
nm
due
reduct
nad
kumar
et
al
crude
extract
transgen
plastid
show
higher
level
badh
activ
compar
untransform
tissu
fig
high
badh
activ
observ
leav
tap
root
cell
suspens
cultur
differ
activ
may
due
variat
plastid
genom
copi
number
high
badh
activ
carrot
taproot
may
due
larg
number
chromoplast
evid
orang
color
fig
also
protein
express
carrot
cell
root
shoot
test
use
western
blot
analysi
fig
result
consist
badh
enzym
activ
also
glycin
betain
found
mani
higher
plant
bacteria
mammalian
anim
accumul
condit
water
salt
stress
act
osmoprotect
figueroasoto
et
al
plant
bacteria
glycin
betain
build
cytoplasm
osmot
strength
without
prevent
cellular
function
badh
report
present
porcin
kidney
local
cortex
medulla
figueroasoto
et
al
carrot
biennial
plant
veget
phase
st
year
reproduct
phase
nd
year
harvest
crop
contain
transgen
end
st
year
prevent
gene
flow
seed
pollen
reproduct
system
also
matern
inherit
carrot
chloroplast
genom
add
environment
friendli
approach
vivek
et
al
somat
embryo
carrot
singlecellderiv
multipli
recurr
embryogenesi
provid
uniform
sourc
cell
cultur
homogen
singl
sourc
requir
product
human
therapeut
protein
oral
deliveri
therapeut
protein
via
edibl
carrot
preserv
structur
integr
protein
cook
need
encapsul
embryo
viabl
mani
year
cultur
use
cryopreserv
advantag
carrot
use
ideal
system
oral
deliveri
cholera
toxin
b
antigencholera
toxin
b
subunit
ctb
vibrio
cholera
candid
vaccin
antigen
express
transgen
chloroplast
result
accumul
total
solubl
protein
function
oligom
daniel
et
al
higher
express
level
tsp
obtain
fusion
protein
express
transgen
chloroplast
molina
et
al
differ
express
level
ctb
gene
due
presenc
ribosomebind
site
ggagg
tsp
utr
psba
gene
tsp
ctb
synthes
transgen
chloroplast
investig
assembl
function
oligom
antigen
ident
purifi
nativ
ctb
ctb
highest
affin
bind
gangliosid
natur
toxin
receptor
intestin
epitheli
cell
function
ctb
determin
elisa
bind
assay
fig
plate
coat
first
bsa
plate
total
solubl
protein
transform
untransform
plant
bacteri
ctb
absorb
complex
measur
bacteri
ctb
chloroplastsynthes
ctb
show
strong
affin
g
complex
confirm
antigen
site
necessari
bind
ctb
conserv
high
level
express
effici
transmucos
carrier
molecul
ctb
chloroplast
fusion
protein
synthes
also
plantderiv
vaccin
commerci
bacillu
anthraci
categori
agent
estim
cost
anthrax
attack
exceed
billion
per
expos
individu
kaufmann
et
al
present
vaccin
anthrax
produc
cellfre
filtrat
toxigen
nonencapsul
strain
b
anthraci
bailli
addit
protect
antigen
pa
immunogen
portion
trace
amount
lethal
factor
edema
factor
present
filtrat
consid
toxic
caus
side
effect
ivin
et
al
bailli
joellenback
et
al
pa
heptamer
bind
host
cell
receptor
bind
lethal
factor
edema
factor
bound
lethal
factor
toxin
stimul
releas
macrophag
cytokin
lead
sudden
death
reason
also
limit
suppli
current
vaccin
biothrax
formerli
anthrax
vaccin
adsorb
ava
urgent
need
improv
pure
vaccin
therefor
b
anthraci
pa
express
transgen
tobacco
chloroplast
pa
gene
clone
chloroplast
transform
vector
along
psba
regulatori
signal
enhanc
translat
crude
plant
extract
contain
mg
pa
g
fresh
weight
daniel
et
al
pa
protein
percentag
total
solubl
protein
express
plant
determin
day
continu
illumin
maximum
pa
total
solubl
protein
achiev
fig
maximum
level
express
observ
matur
leav
continu
illumin
also
western
blot
perform
use
two
differ
deterg
extract
buffer
chap
sd
extract
pa
equal
well
storag
day
pa
crude
extract
quit
stabl
powder
leaf
store
sever
month
western
blot
perform
show
notic
decreas
pa
quantiti
function
facilit
longterm
storag
harvest
leav
pa
extract
vaccin
product
trypsin
chymotrypsin
furin
proteolyt
site
present
pa
express
transgen
chloroplast
protect
pa
observ
function
antigen
determin
abil
intern
lethal
factor
caus
lysi
cultur
macrophag
cell
term
macrophag
lysi
assay
fig
percentag
macrophag
viabil
determin
use
abil
live
dead
cell
reduc
watersolubl
yellow
dye
bromid
insolubl
purpl
formazan
product
daniel
et
al
pa
also
show
heptamer
cleav
properli
averag
yield
mg
pa
per
plant
use
experiment
transgen
cultivar
grown
greenhous
million
dose
vaccin
free
contamin
could
produc
per
acr
yield
could
increas
commerci
cultivar
use
rather
experiment
cultivar
plagu
vaccin
antigenyersinia
pesti
gramneg
bacterium
caus
agent
plagu
list
center
diseas
control
cdc
one
six
categori
biolog
agent
three
differ
form
plagu
bubon
plagu
common
form
plagu
caus
infect
flea
enter
lymph
node
bacterium
caus
swell
node
form
bubo
form
septicem
plagu
pneumat
plagu
current
vaccin
avail
kill
whole
subunit
vaccin
moder
effect
bubon
plagu
ineffect
two
form
plagu
titbal
williamson
sever
subunit
vaccin
evalu
immunogen
pesti
lcrv
effect
subunit
vaccin
far
pesti
capsular
protein
locat
surfac
bacterium
antiphagocyt
properti
v
antigen
compon
pesti
type
iii
secret
system
may
form
part
injectosom
fusion
protein
express
e
coli
shown
safe
immunogen
mice
challeng
pesti
williamson
et
al
fusion
protein
express
transgen
chloroplast
consist
antigen
fuse
carboxi
terminu
amino
terminu
v
antigen
western
blot
elisa
perform
sampl
collect
plant
continu
illumin
day
young
matur
old
leav
fig
maximum
express
level
observ
matur
leav
high
total
solubl
protein
arlen
et
al
studi
need
done
confirm
immunogen
sinc
pesti
one
categori
biolog
warfar
agent
proper
vaccin
improv
vaccin
high
prioriti
canida
wolv
south
american
dog
asiat
raccoon
dog
produc
hemorrhag
gastroenter
myocard
cpv
vaccin
cornel
univers
synthet
peptid
coupl
klh
carrier
protein
studi
extens
shown
effect
protect
dog
mink
parvoviru
langeveld
et
al
langeveld
et
al
peptid
confer
protect
dog
virul
canin
parvoviru
cpv
express
tobacco
chloroplast
fusion
protein
cholera
toxin
b
ctb
green
fluoresc
protein
gfp
maximum
level
protein
express
achiev
mgg
fresh
weight
equival
total
solubl
protein
mgg
fresh
weight
equival
total
solubl
protein
molina
et
al
fig
express
level
also
depend
age
plant
matur
plant
accumul
highest
amount
protein
compar
young
senesc
plant
show
import
plant
harvest
time
also
chimer
protein
retain
pentamer
g
gangliosidebind
properti
nativ
ctb
mice
immun
intraperiton
leaf
extract
mice
immun
elicit
antibodi
abl
recogn
protein
cpv
fig
first
report
anim
vaccin
viral
antigen
express
transgen
chloroplast
sever
human
therapeut
protein
express
transgen
chloroplast
list
tabl
express
level
depend
site
integr
regulatori
element
use
enhanc
transcriptiontransl
effici
stabil
foreign
protein
gene
encod
protein
small
amino
acid
magainin
degray
et
al
larg
kda
pa
daniel
et
al
express
transgen
chloroplast
illustr
daniel
laboratori
describ
follow
section
human
serum
albuminhuman
serum
albumin
hsa
wide
use
intraven
protein
obtain
fraction
blood
serum
account
approxim
total
protein
blood
et
al
world
need
ton
annual
repres
market
valu
billion
hsa
produc
wide
varieti
microbi
system
system
commerci
feasibl
yet
express
function
hsa
transgen
chloroplast
express
system
advantag
inexpens
product
cost
absenc
human
pathogen
protein
express
transgen
chloroplast
translat
control
shine
dalgarno
sequenc
psba
region
utr
differ
express
level
obtain
transgen
plant
differ
regulatori
sequenc
exampl
pot
transgen
plant
regul
shinedalgarno
sequenc
show
tsp
tsp
hsa
observ
plant
regul
chloroplast
psba
heterolog
utr
respect
express
seedl
shinedalgarno
control
total
protein
hsa
tp
observ
psba
control
tp
utr
control
low
level
hsa
accumul
matur
plant
control
sd
may
due
excess
proteolyt
degrad
poor
rate
translat
psba
region
lightregul
continu
light
illumin
h
hsa
quantiti
matur
leav
maximum
total
solubl
protein
et
al
greater
express
previou
report
nuclear
express
hsa
observ
form
inclus
bodi
transgen
chloroplast
thu
offer
protect
proteolyt
degrad
fig
inclus
bodi
easili
separ
major
cellular
protein
centrifug
therebi
elimin
need
expens
affin
column
chromatograph
techniqu
properli
fold
hsa
recov
inclus
bodi
denatur
complet
solubil
vitro
refold
et
al
human
interferon
alphahuman
interferon
use
treatment
malign
carcinoid
tumor
shown
effect
reduct
tumor
size
therapeut
valu
inhibit
viral
replic
cell
prolifer
enhanc
immun
respons
recent
treatment
patient
suffer
west
nile
viru
infect
present
protein
produc
e
coli
commerci
use
also
requir
vitro
process
purif
nuclear
express
protein
also
result
low
express
tsp
tobacco
elderbaum
et
al
altogeth
made
treatment
interferon
expens
averag
cost
per
year
recombin
express
transgen
chloroplast
use
chloroplast
transform
vector
integr
gene
cassett
includ
gene
along
polyhistidin
purif
tag
thrombin
cleavag
site
fig
western
blot
perform
detect
multim
monom
use
interferon
alpha
monoclon
antibodi
confirm
format
disulfid
bond
integr
gene
cassett
chloroplast
genom
confirm
southern
blot
elisa
perform
quantifi
protein
express
total
solubl
protein
obtain
arlen
et
al
function
investig
abil
protect
hela
cell
cytopath
effect
encephalomyocard
viru
emc
identif
interferoninduc
transcript
fig
chloroplast
deriv
found
activ
commerci
produc
intron
mrna
level
two
gene
induc
oligoadenyl
synthas
test
rtpcr
use
primer
specif
gene
chloroplastderiv
induc
express
gene
manner
similar
commerci
confirm
chloroplast
deriv
activ
commerci
produc
intron
human
insulinlik
growth
insulinlik
growth
factor
therapeut
valu
mediat
growth
muscl
tissu
therapeut
valu
current
evalu
diabet
igfi
induc
neuroprotect
promot
bone
heal
natur
occur
singlechain
polypeptid
three
disulfid
bond
produc
liver
torrado
carrascosa
produc
e
coli
produc
matur
form
disulfid
bond
form
e
coli
cytoplasm
sinc
codon
suitabl
eukaryot
environ
codon
optim
chloroplast
increas
level
express
transgen
chloroplast
pcr
southern
blot
analysi
confirm
chloroplast
integr
gene
elisa
perform
quantifi
express
level
nativ
synthet
gene
transgen
chloroplast
express
level
high
total
solubl
protein
ruiz
fig
howev
quantif
express
complic
zztag
use
purif
level
express
verifi
use
antibodi
crossreact
zztag
observ
suggest
unlik
bacteri
translat
machineri
chloroplast
translat
machineri
may
quit
flexibl
antimicrobi
peptideantimicrobi
peptid
amp
common
compon
innat
defens
mechan
anim
kingdom
help
combat
pathogen
control
normal
microbi
flora
magainin
secret
skin
african
claw
frog
xenopu
laevi
broadspectrum
topic
agent
system
antibiot
woundheal
anticanc
agent
zasloff
jacob
zasloff
degray
et
al
magainin
affin
neg
charg
phospholipid
outer
leaflet
prokaryot
membran
magainin
analog
express
transgen
chloroplast
express
level
total
solubl
protein
obtain
degray
et
al
daniel
et
al
effect
lytic
peptid
express
transgen
chloroplast
test
multidrug
resist
gramneg
bacterium
pseudomona
aeruginosa
result
growth
inhibit
pathogen
fig
effect
pseudomona
syringa
requir
bacteria
base
studi
minimum
inhibitori
concentr
chloroplastderiv
human
antibodymonoclon
antibodi
passiv
immunotherapi
wide
studi
therapeut
protein
produc
transgen
plant
though
larg
number
therapeut
protein
produc
plant
enter
clinic
trial
antistreptococcu
mutan
secretori
antibodi
prevent
dental
cari
plantderiv
antibodi
current
phase
ii
clinic
trial
larrick
thoma
base
chloroplast
abil
form
fulli
activ
assembl
protein
codonoptim
human
gene
encod
chimer
monoclon
antibodi
igag
guy
control
specif
region
use
synthes
monoclon
antibodi
transgen
chloroplast
guy
develop
prevent
dental
cari
caus
streptococcu
mutan
daniel
wycoff
daniel
et
al
integr
chimer
antibodi
gene
chloroplast
genom
confirm
pcr
southern
blot
analysi
western
blot
analysi
show
express
heavi
light
chain
well
fulli
assembl
antibodi
fig
suggest
presenc
chaperon
proper
protein
fold
enzym
format
disulfid
bond
transgen
chloroplast
howev
express
level
enhanc
facilit
commerci
chloroplast
genet
engin
approach
ideal
econom
product
vaccin
antigen
biopharmaceut
environment
friendli
manner
proven
function
high
express
level
vaccin
antigen
therapeut
protein
transgen
chloroplast
hold
promis
unlimit
quantiti
product
cost
purif
still
prohibit
overcom
oral
deliveri
vaccin
antigen
therapeut
protein
use
novel
purif
strategi
describ
review
bind
elisa
assay
plate
coat
first
bovin
serum
albumin
bsa
respect
irrig
total
solubl
plant
protein
chloroplast
transgen
line
ng
purifi
bacteri
ctb
absorb
complex
case
measur
nm
total
solubl
protein
untransform
plant
use
neg
control
macrophag
cytotox
assay
extract
transgen
plant
supernat
sampl
test
protein
extract
buffer
contain
deterg
mtt
ad
h
extract
store
day
extract
store
day
pa
control
wild
type
extract
store
day
control
wild
type
extract
store
day
control
wild
type
lf
extract
store
day
control
wild
type
lf
extract
store
day
control
lf
extract
store
day
control
lf
extract
store
day
demonstr
function
abil
protect
hela
cell
cytopath
effect
encephalomyocard
viru
note
chloroplast
deriv
activ
commerci
produc
intron
express
transgen
chloroplast
continu
illumin
day
express
shown
percentag
total
solubl
protein
nativ
gene
chloroplast
codonoptim
gene
vitro
bioassay
gener
chloroplast
transgen
line
p
aeruginosa
bacteri
cell
overnight
cultur
dilut
incub
h
g
total
protein
extract
lb
ml
ad
sampl
incub
overnight
absorb
record
nm
data
analyz
use
graph
pad
prism
